PMC:7195088 / 15932-16132 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"740","span":{"begin":135,"end":141},"obj":"Chemical"},{"id":"741","span":{"begin":164,"end":168},"obj":"Chemical"}],"attributes":[{"id":"A740","pred":"tao:has_database_id","subj":"740","obj":"MESH:D010100"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"oniae. Open-label RCT (NCT04261907, not yet recruiting). Primary endpoint: adverse outcome at day 14 (composite of Spo 2 ≤ 93% without oxygen supplementation, PaO2/FiO2 ≤ 300 mm Hg or respiratory rate"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T60","span":{"begin":12,"end":17},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"},{"id":"T61","span":{"begin":119,"end":125},"obj":"http://purl.obolibrary.org/obo/CLO_0001230"},{"id":"T62","span":{"begin":119,"end":125},"obj":"http://purl.obolibrary.org/obo/CLO_0037237"},{"id":"T63","span":{"begin":119,"end":125},"obj":"http://purl.obolibrary.org/obo/CLO_0050903"},{"id":"T64","span":{"begin":119,"end":125},"obj":"http://purl.obolibrary.org/obo/CLO_0054249"},{"id":"T65","span":{"begin":119,"end":125},"obj":"http://purl.obolibrary.org/obo/CLO_0054250"},{"id":"T66","span":{"begin":119,"end":125},"obj":"http://purl.obolibrary.org/obo/CLO_0054251"},{"id":"T67","span":{"begin":119,"end":125},"obj":"http://purl.obolibrary.org/obo/CLO_0054252"}],"text":"oniae. Open-label RCT (NCT04261907, not yet recruiting). Primary endpoint: adverse outcome at day 14 (composite of Spo 2 ≤ 93% without oxygen supplementation, PaO2/FiO2 ≤ 300 mm Hg or respiratory rate"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T96","span":{"begin":12,"end":17},"obj":"Chemical"},{"id":"T97","span":{"begin":135,"end":141},"obj":"Chemical"},{"id":"T98","span":{"begin":178,"end":180},"obj":"Chemical"}],"attributes":[{"id":"A96","pred":"chebi_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A97","pred":"chebi_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A98","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_16170"},{"id":"A99","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_25195"}],"text":"oniae. Open-label RCT (NCT04261907, not yet recruiting). Primary endpoint: adverse outcome at day 14 (composite of Spo 2 ≤ 93% without oxygen supplementation, PaO2/FiO2 ≤ 300 mm Hg or respiratory rate"}

{"project":"LitCovid-sentences","denotations":[{"id":"T100","span":{"begin":7,"end":56},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"oniae. Open-label RCT (NCT04261907, not yet recruiting). Primary endpoint: adverse outcome at day 14 (composite of Spo 2 ≤ 93% without oxygen supplementation, PaO2/FiO2 ≤ 300 mm Hg or respiratory rate"}